Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-16-001567
Filing Date
2016-02-09
Accepted
2016-02-09 18:37:13
Documents
1
Period of Report
2016-02-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 7392
  Complete submission text file 0001562180-16-001567.txt   8787
Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Issuer) CIK: 0001557883 (see all company filings)

EIN.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DERMIRA, INC. 2055 WOODSIDE ROAD REDWOOD CITY CA 94061
Business Address
Griffith Christopher M. (Reporting) CIK: 0001620520 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36668 | Film No.: 161401559